iBio, Inc. Uncategorized Contracts & Agreements
21 Contracts & Agreements
- Side Letter Agreement dated April 1, 2024 (Filed With SEC on April 1, 2024)
- Form of the Tail Warrants (Filed With SEC on December 8, 2023)
- Form of Series D Common Warrants (Filed With SEC on December 6, 2023)
- Form of Series C Common Warrants (Filed With SEC on December 6, 2023)
- Form of Pre-Funded Warrants (Filed With SEC on December 6, 2023)
- Exhibit Description (Filed With SEC on March 30, 2023)
- Offer Letter by and between iBio, Inc. and Felipe Duran dated January 23, 2023 (Filed With SEC on January 25, 2023)
- Form of Representatives Warrants (Filed With SEC on December 8, 2022)
- Form of Series B Warrants (Filed With SEC on December 8, 2022)
- Form of Series A Warrants (Filed With SEC on December 8, 2022)
- Environmental Indemnity Agreement, dated November 1, 2021 by iBio CDMO LLC and iBio, Inc. in favor of Woodforest National Bank (Filed With SEC on November 4, 2021)
- Description of Securities of iBio, Inc (Filed With SEC on September 28, 2021)
- Second Amended and Restated Right of First Refusal and Co-Sale Agreement, dated August 23, 2021, by and among RubrYc Therapeutics, Inc. and certain investors (Filed With SEC on August 27, 2021)
- Director Offer Letter (Filed With SEC on August 26, 2021)
- Director Offer Letter (Filed With SEC on June 9, 2021)
- Description of Securities of iBio, Inc (Filed With SEC on October 13, 2020)
- Statement of Work 2, dated February 6, 2020, between the Company and Beijing CC-Pharming Ltd (Filed With SEC on March 13, 2020)
- Form of Leak-Out Agreement (Filed With SEC on October 28, 2019)
- Form of Leak-Out Agreement (Filed With SEC on October 24, 2019)
- COMMON STOCKPURCHASE AGREEMENT (Filed With SEC on August 26, 2014)
- ConfidentialMaterials omitted and filed separately with the Securities and Exchange Commission -- Doubleasterisks denote omissions -- EBY CONNER SMILLIE & BOURQUE, PLLC... (Filed With SEC on September 30, 2013)
